Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-22,350
Closed -$2.77M 132
2018
Q4
$2.77M Sell
22,350
-5,004
-18% -$824K 0.1% 96
2018
Q3
$6.68M Buy
27,354
+626
+2% +$145K 0.19% 72
2018
Q2
$4.98M Sell
26,728
-20,912
-44% -$3.48M 0.15% 83
2018
Q1
$5.85M Sell
47,640
-1,205
-2% -$147K 0.14% 83
2017
Q4
$5.82M Buy
48,845
+1,027
+2% +$113K 0.15% 83
2017
Q3
$4.55M Sell
47,818
-16,089
-25% -$1.55M 0.1% 93
2017
Q2
$6.1M Buy
63,907
+5,429
+9% +$464K 0.15% 85
2017
Q1
$4.54M Sell
58,478
-13,739
-19% -$952K 0.12% 80
2016
Q4
$4.85M Buy
72,217
+48,678
+207% +$3M 0.14% 78
2016
Q3
$1.41M Buy
+23,539
New +$1.31M 0.04% 100

Other funds holding INGN

Axiom Investors's INGN Position: Q1 2019 in Review

Axiom Investors sold out of Inogen (INGN) in Q1 2019, closing a stake of 22,350 shares — an estimated $2.77M sold.

Axiom Investors first reported a position in INGN in Q3 2016 and held it in 10 quarters. The position peaked at $6.68M in Q3 2018. 239 funds tracked by Wall St. Rank hold INGN as of Q1 2019.

  • Axiom Investors reported no remaining Inogen position as of Q1 2019 after selling out during the quarter.
  • Axiom Investors sold 22,350 Inogen shares in Q1 2019, an estimated $2.77M.
  • Axiom Investors first reported a position in Inogen in Q3 2016 and held it in 10 quarters.
  • Axiom Investors's Inogen position peaked at $6.68M in Q3 2018.
  • 239 funds tracked by Wall St. Rank held Inogen as of Q1 2019.

Based on Axiom Investors's 13F filing for Q1 2019, filed 13 May 2019.